We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAXW
401
DELISTED
Alset Capital Acquisition Corp Warrant
ACAXW
$11K ﹤0.01%
164,181
+10,092
+7% +$676
ENERR
402
DELISTED
Accretion Acquisition Corp Right
ENERR
$11K ﹤0.01%
120,600
– –
SBIGW
403
DELISTED
SpringBig Holdings, Inc. Warrant
SBIGW
$11K ﹤0.01%
213,763
+50,404
+31% +$6.08K
HMACR
404
DELISTED
Hainan Manaslu Acquisition Corp. Right
HMACR
$11K ﹤0.01%
+150,000
New +$11.5K
RKLY.WS
405
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$11K ﹤0.01%
113,925
+10,900
+11% +$2.34K
TZPSW
406
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$11K ﹤0.01%
122,065
+100,000
+453% +$7.58K
GNACW
407
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$11K ﹤0.01%
185,335
+24,887
+16% +$2.57K
JOFFW
408
DELISTED
JOFF Fintech Acquisition Corp. Warrant
JOFFW
$11K ﹤0.01%
297,475
+26,833
+10% +$1.87K
MEOAW
409
DELISTED
Minority Equality Opportunities Acquisition Inc. Warrants
MEOAW
$11K ﹤0.01%
124,298
-100
-0.1% -$6
OPTXW icon
410
Syntec Optics Holdings Warrant
OPTXW
$22.9M
$10K ﹤0.01%
144,019
+15,500
+12% +$1.67K
ABVEW
411
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$10K ﹤0.01%
165,930
+115,930
+232% +$12.1K
PORT.WS
412
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$10K ﹤0.01%
96,822
– –
PEPLW
413
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$10K ﹤0.01%
130,264
+2,507
+2% +$362
ROIVW
414
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$10K ﹤0.01%
+24,563
New +$13.1K
APMIW
415
DELISTED
AxonPrime Infrastructure Acquisition Corporation Warrants
APMIW
$10K ﹤0.01%
100,000
-61,240
-38% -$10.4K
GSQB.WS
416
DELISTED
G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GSQB.WS
$10K ﹤0.01%
101,700
– –
CCRN
417
DELISTED
Cross Country Healthcare
CCRN
$9K ﹤0.01%
+30,000
New +$771K
GDSTW
418
DELISTED
Goldenstone Acquisition Limited Warrants
GDSTW
$9K ﹤0.01%
444,976
– –
CLDI.WS
419
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$9K ﹤0.01%
158,100
+33,400
+27% +$2.01K
CMCAW
420
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$9K ﹤0.01%
99,300
– –
AONCW
421
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$9K ﹤0.01%
+125,000
New +$12.2K
ACAHW
422
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
$9K ﹤0.01%
223,099
+95,654
+75% +$4.95K
BTWNW
423
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$9K ﹤0.01%
77,028
– –
VBOCW
424
DELISTED
Viscogliosi Brothers Acquisition Corp Warrant
VBOCW
$9K ﹤0.01%
100,000
+75,000
+300% +$9K
MSACW
425
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$9K ﹤0.01%
+52,887
New +$10.1K
15 16
17
18 19

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.